Single Dose Novel Salmonella Vaccine Enhances Resistance against Visceralizing L. major and L. donovani Infection in Susceptible BALB/c Mice

Vaccines for Leishmaniasis: From proteome to vaccine candidates

(2011) Juliane Schroeder et al.   Human vaccines & immunotherapeutics

Vaccines for the Leishmaniases: Proposals for a Research Agenda

(2011) et al.   PLoS Neglected Tropical Diseases

Murine visceral leishmaniasis: IgM and polyclonal B-cell activation lead to disease exacerbation

(2010) Eszter Deak et al.   EUROPEAN JOURNAL OF IMMUNOLOGY

Vaccines and vaccination strategies against human cutaneous leishmaniasis

(2010) Ifeoma Okwor et al.   Human vaccines & immunotherapeutics

A clinical trial to evaluate the safety and immunogenicity of the LEISH-F1+MPL-SE vaccine when used in combination with meglumine antimoniate for the treatment of cutaneous leishmaniasis

(2010) Evaldo Nascimento et al.   VACCINE

Cost-Effectiveness Analysis of Combination Therapies for Visceral Leishmaniasis in the Indian Subcontinent

(2010) Filip Meheus et al.   PLoS Neglected Tropical Diseases

Salmonella enterica serovar Typhi live vector vaccines finally come of age

(2009) James E Galen et al.   IMMUNOLOGY AND CELL BIOLOGY

Vaccine development against Trypanosoma cruzi and Leishmania species in the post-genomic era

(2009) Eric Dumonteil   INFECTION GENETICS AND EVOLUTION

Priming of Salmonella enterica Serovar Typhi-Specific CD8+ T Cells by Suicide Dendritic Cell Cross-Presentation in Humans

(2009) Rosângela Salerno-Goncalves et al.   PLoS One

Proteome-Based Analysis of Serologically Defined Tumor-Associated Antigens in Cutaneous Lymphoma

(2009) Michael Forgber et al.   PLoS One

Efficacy of killed whole-parasite vaccines in the prevention of leishmaniasis—A meta-analysis

(2009) Sassan Noazin et al.   VACCINE

Decrease of the incidence of human and canine visceral leishmaniasis after dog vaccination with Leishmune® in Brazilian endemic areas

(2009) Clarisa B. Palatnik-de-Sousa et al.   VACCINE

KMP-11 DNA immunization significantly protects against L. donovani infection but requires exogenous IL-12 as an adjuvant for comparable protection against L. major

(2009) Suniti Bhaumik et al.   VACCINE

Recombinant outer membrane vesicles to augment antigen-specific live vaccine responses

(2009) Juliane Schroeder et al.   VACCINE

Correlation of T cell response and bacterial clearance in human volunteers challenged with Helicobacter pylori revealed by randomised controlled vaccination with Ty21a-based Salmonella vaccines

(2008) T Aebischer et al.   GUT

Transgenic, FluorescentLeishmania mexicanaAllow Direct Analysis of the Proteome of Intracellular Amastigotes

(2008) Daniel Paape et al.   MOLECULAR & CELLULAR PROTEOMICS

Evaluation of an immunochemotherapeutic protocol constituted of N-methyl meglumine antimoniate (Glucantime®) and the recombinant Leish-110f®+MPL-SE® vaccine to treat canine visceral leishmaniasis

(2008) Jorge Miret et al.   VACCINE

Vaccines for leishmaniasis in the fore coming 25 years

(2008) Clarisa B. Palatnik-de-Sousa   VACCINE

An Oral Recombinant Vaccine in Dogs against Echinococcus granulosus, the Causative Agent of Human Hydatid Disease: A Pilot Study

(2008) Anne-Francoise Petavy et al.   PLoS Neglected Tropical Diseases

Retooling Leishmania metabolism: from sand fly gut to human macrophage

(2007) Doron Rosenzweig et al.   FASEB JOURNAL

A vaccine against Helicobacter pylori: Towards understanding the mechanism of protection

(2007) Toni Aebischer et al.   INTERNATIONAL JOURNAL OF MEDICAL MICROBIOLOGY